0.00Open0.00Pre Close0 Volume0 Open Interest965.00Strike Price0.00Turnover5833.68%IV-25.74%PremiumJan 3, 2025Expiry Date197.52Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9953Delta0.0002Gamma--Leverage Ratio-534.8516Theta0.0000Rho0.00Eff Leverage0.0001Vega
Eli Lilly and Co Stock Discussion
US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website
$Eli Lilly and Co (LLY.US)$
$Eli Lilly and Co (LLY.US)$
No comment yet